Aethlon Medical Inc. has announced a 1-for-10 reverse stock split of its common shares, effective October 16, 2025. The company's stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market starting October 20, 2025, under the existing symbol "AEMD." The CUSIP number for the common stock will change to 00808Y604.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-25-007586), on October 16, 2025, and is solely responsible for the information contained therein.
Comments